Joshua Taggart knew he wanted to work for the space industry the day he experienced his first launch while attending a camp at Kennedy Space Center, seeing the space shuttle Endeavour soar into the sky. He’s now closer to making that dream a reality after being recognized with one of the industry’s most distinguished awards.

Taggart is the latest Knight to receive the coveted Astronaut Foundation Scholarship, a national award that provides more than 70 scholarships of up to $15,000 each for some of the nation’s very best STEM students. He will be recognized with the 2026 class of scholars at the foundation’s gala, to be held next month in Houston.

Taggart says he chose �鶹ӳ����ý for its reputation in engineering as the No. 1 supplier of talent to the nation’s aerospace and defense industries (Aviation Week Network). He is in good company as part of a trio of Astronaut Scholars this year from the College of Engineering and Computer Science, joining mechanical engineering student Keanu Brayman and computer engineering student Kyle Coutray (a biomedical sciences double major), who have received the scholarship for second consecutive year.

As Taggart works to complete his final year at �鶹ӳ����ý, his latest accomplishment fuels his path to make an impact as a future space researcher.

Future Focused

Driven to contribute to humanity’s exploration of our universe, Taggart is already working on future-focused innovations that can benefit the space industry.

Through NASA Office of STEM Engagement, he interned at the Johnson Space Center working on communications, avionics, propulsion and flight software for CubeSat subsystems.

This summer at NASA’s Glenn Research Center, he is researching packaging materials for silicon carbide pressure sensors, working to make sure they perform reliably above 1,000 degrees Celsius (1,832 degrees Fahrenheit), and on integrating thermocouple sensors for temperature compensation.

“I chose this field of research because I want to be involved in next-generation electronics that can withstand the extreme nature of outer space.” — Joshua Taggart

“With the harsh environment that outer space is and planet surfaces like Venus, electronics must survive very high temperatures and radiation effects,” he says. “I chose this field of research because I want to be involved in next-generation electronics that can withstand the extreme nature of outer space.”

His work as an undergraduate researcher for the Q-Sim Lab, directed by Assistant Professor Jaesung Lee, also centers around developing technology designed to operate in outer space. Taggart is working on microelectromechanical systems (MEMS) resonators designed to perform under extreme conditions, such as elevated temperatures and increased exposure to radiation.

He recently won a Judge’s Choice Award at �鶹ӳ����ý Student Research Week for his Honors Undergraduate Thesis, “Robust AlN MEMS Resonators for High Temperature Space Environments.”

His passion for space has only grown over the years, reflected by his ongoing research at �鶹ӳ����ý and for NASA. As an Astronaut Scholar, Taggart is launching into a future full of possibilities.

“Aside from the financial support that this scholarship will provide me as I complete my undergraduate program, I am very eager for all of the networking opportunities I will have,” Taggart says. “I look forward to networking with other students and industry leaders to learn and grow as much as I can thanks to the Astronaut Scholarship Foundation.”

Those interested in the Astronaut Scholarship and other opportunities should reach out to the Office of Prestigious Awards at��OPA@ucf.edu.

Worth noting among this graduating class:

• Roughly 30% of the undergraduate students receiving their degrees are the first in their families to earn their diploma.
• More than 25% of this term’s degrees are tied to STEM majors.
• About 30% of the undergraduate graduating class are Pell Grant recipients.

�鶹ӳ����ý is the leading producer of talent among Florida’s universities, awarding roughly 19,000 degrees annually to Knights who go on to work in high-demand industries. About 85% of our alumni stay in Florida because of the ample opportunity to thrive as part of our state’s workforce.

Graduates will hear from��three��esteemed speakers��— all �鶹ӳ����ý graduates —��whose leadership and impact��have��benefited��our region:

• Psychology alum��Allen Johnson��’81,��chief��venue��officer for��City��for��Orlando Venues
• Journalism alum Tanya (Easterling) Hill ’97, market president for Central Florida for Florida Blue
• Criminal��justice��alum��Fred Kittinger ’80, �鶹ӳ����ý’s former��senior associate vice president for government and community relations

Commencement Festivities

Held in the Addition Financial Arena, summer commencement will take place over three ceremonies spanning Friday, July 31, and Saturday, Aug. 1.

All guests, including children and infants, need a ticket for admission. All graduates who have filed an intent to graduate will receive five commencement ceremony tickets when they pick up their regalia packet.

Guests who do not have tickets may watch the live ceremony via a simulcast viewing in the FAIRWINDS Alumni Center and the Student Union. Ceremonies will also be .

Commencement Photo-ops Across �鶹ӳ����ý

Graduating Knights are unable to take photos at the Acrisure Bounce House football stadium this semester due to ongoing construction.

Grad Walk

On Thursday,��July��30,��4:30-7 p.m. (doors close at 6 p.m.),��summer��graduates are invited to a photo-op — Grad Walk — within the Addition Financial Arena. This will be a first-come, first-served occasion for graduates and up to 10 of their well-wishers to take photos and videos on the ceremony stage. Graduates��are required to��register at��.

Commencement Schedule

Graduates and guests can review the below commencement ceremony schedule, listing colleges, ceremony��dates��and streaming links:

Friday,��July��31

6��p.m.

College of Arts and Humanities

College of Community Innovation and Education

College of Graduate Studies

Rosen College of Hospitality Management

Saturday,��Aug. 1

9 a.m.

Barry S. Miller��College of Business

College of Health Professions and Sciences

College of Medicine

College of Nursing

2:30��p.m.

College of Engineering and Computer Science

College of Optics and Photonics

College of Sciences

For more details and FAQs about��Summer��2026 commencement celebrations, visit��ucf.edu/graduation.

Commencement Speakers

Allen Johnson ’81

Chief Venues Officer, City of Orlando Venues

Allen Johnson ’81 has served as chief venues officer of Orlando Venues since 2004, overseeing the City of Orlando’s diverse portfolio of Kia Center, Camping World Stadium, Tinker Field, Leu Gardens and the Mennello Museum of American Art.

Johnson brings decades of venue management experience from leadership roles across Florida. Under Johnson’s leadership, Orlando Venues has evolved into a premier, globally recognized destination for sports, entertainment and culture, welcoming millions of guests each year while strengthening Central Florida’s reputation as a world-class destination.

A proud �鶹ӳ����ý graduate with a bachelor’s degree in psychology, he has earned numerous honors, including the 2025 International Association of Venue Managers Foundation Legacy Award, the SPORTYS Executive of the Year Award and the Downtowner of the Year Award.

He remains active in the International Association of Venue Managers (IAVM), serving as past chairman and trustee of the foundation board, while also contributing to organizations that include the Greater Orlando Sports Commission, Florida Citrus Sports, Victim Service Center and the .

Tanya (Easterling) Hill ’97

Market President for Central Florida, Florida Blue

Tanya Hill ’97��is Florida Blue’s market president for Central Florida,��responsible for��regional business and community engagement in a 9-county region.

Throughout her more than 25-year career, she has worked with reputable brands including Chick-fil-A, Target and Walt Disney World to drive business results through strategic partnerships.

Hill is passionate about investing time in the community and has been involved with��numerous��community and civic organizations. She currently serves on the board of directors for the��African American Chamber of Commerce of Central Florida, 4Roots Foundation, Orlando Economic��Partnership��and the Winter Park Health Foundation.

Hill holds a bachelor’s degree in journalism from �鶹ӳ����ý.

Fred Kittinger ’80

Former Senior Associate Vice President for Government and Community Relations, �鶹ӳ����ý

A native of central Florida, Fred Kittinger ’80 recently retired as senior associate vice president for government and community relations at �鶹ӳ����ý, where he served for more than 22 years.

He worked alongside local and state leaders to help foster some of �鶹ӳ����ý’s most transformative achievements, including the approval of �鶹ӳ����ý’s College of Medicine, the creation of the world-class Florida Interactive Entertainment Academy, the development of �鶹ӳ����ý Downtown, the expansion of the �鶹ӳ����ý Business Incubation Program and investments that enhanced the student experience and advanced regional impact.

Prior to his career at �鶹ӳ����ý, Kittinger served as chief of staff to Orlando Mayor Glenda Hood and previously as vice president of government relations for the Greater Orlando Chamber of Commerce. He began his career as a legislative aide to state Senator George Stuart of Orlando.

Reflecting his commitment to the community, Kittinger currently serves on the board of directors for Junior Achievement of Central Florida (past chair), Central Florida Council for Scouting America and Legacy Pointe at �鶹ӳ����ý.

Kittinger graduated from �鶹ӳ����ý’s criminal justice program and earned his master’s degree in public administration from Florida State University.

�鶹ӳ����ý Professor Michal Masternak and his team have identified molecular changes in the liver that happen when space travelers experience radiation and microgravity. These changes – that resemble accelerated aging – provide new insight into how prolonged space missions may increase health risks for astronauts and reveal potential targets for therapies that could combat age-related diseases on Earth.

“Just 24 hours after radiation exposure, there are many genetic changes in the liver that are remarkably similar to what happens during aging.” — Professor Michal Masternak

“We focused on the liver because it is one of the major metabolic organs in our body,” says Masternak, leader of the College of Medicine’s aging and space medicine research efforts. “What we found was that just 24 hours after radiation exposure, there are many genetic changes in the liver that are remarkably similar to what happens during aging. We can assume that if someone were in space much longer, the damage could be much greater.”

The findings were recently published in��GeroScience.

Navigating the Science

For their study, �鶹ӳ����ý researchers and scientists from the U.S. created a simulated deep space environment in the lab. The team exposed animal models to simulated microgravity for 14 days and galactic cosmic radiation and solar particle events at NASA Space Radiation Laboratory trying to mimic the dosage that astronauts would be exposed to during a trip to Mars.

The exposure triggered noticeable and potentially harmful changes in the liver, including increased cellular senescence (aging and decreased cell function), inflammation and fibrosis. Left untreated, these conditions can eventually lead to declining and even failing organ function.

The research team then compared their results with data collected from astronaut blood samples taken during the NASA Twins Study and Inspiration4 astronauts. They saw similar genetic changes in blood.

“We’ve got this raw data from human studies, and they show that some of these changes are similar,” Masternak says. “That tells us we’re identifying useful molecular targets that one day could help protect astronauts during long-duration space missions.”

They��also��went a step further to see��whether the��changes could be treated. They��identified��a group of molecules known as antagomirs that alter several aging and inflammatory genetic pathways��by interacting with the body’s��microRNA. This system could pinpoint promising��future��therapies for space travelers.

Understanding Aging in the Space Age

Masternak says��the nation’s��growing space industry provides a unique opportunity to study aging at an accelerated pace.

“Very often when we study different aging processes, it takes time,” he says. “Even in humans, it’s almost impossible because it would take decades. But if we see some acceleration of aging in space, then we can translate it to human studies. We can observe processes happening much faster, understand them better and eventually use that knowledge to improve health for people here on Earth.”

“If we see some acceleration of aging in space, then … we can observe processes happening much faster, understand them better and eventually use that knowledge to improve health for people here on Earth.” — Masternak

Those discoveries could eventually lead to therapies that slow age-related diseases, preserve organ function and improve quality of life for everyone as they age.

“Our understanding of aging is very complex,” Masternak says. “Aging isn’t simply wrinkles or cosmetic changes. It’s the gradual and cascading failure of multiple organs and biological systems that happen at the same time. By understanding what starts that process and where it happens, we have a better chance of preventing many diseases before they develop. That is one of the biggest outstanding questions.”

Students Positioned at the Forefront of Space Medicine

College of Medicine students are also benefitting from space medicine research. Biomedical sciences Ph.D. student Md��Tanjim Alam��’25MS��joined Masternak’s laboratory during his��biotechnology��master’s program after initially planning to study cancer in relation to aging biology. Then he was introduced to space medicine, including processing astronaut samples from commercial space travelers to study how extreme environments affect human biology. That research has inspired him.

“I want to keep exploring the unknown,” Alam says. “I really want to understand how space travel influences human health, particularly its effects on aging and cancer.”

Biotechnology��graduate��student��Sarah��S.��Siddiqi��’24��says the interdisciplinary nature of the research attracted her to the space medicine and aging lab.

“When people think of aging, they think only about elderly populations,” says Siddiqi, who earned her bachelor’s degree as a Burnett Honors Scholar in biomedical sciences. “But we study aging across different stages of life and different environments, including space. I’ll always be focused on improving quality of life. I want to better understand diseases that are increasingly prevalent and find ways to recognize them earlier, before they progress to later stages.”

Funding and Disclosure:

Representing���鶹ӳ����ý,��Natalie Hayslip��’24��served as first author, while��Sarah Ashiqueali��’21MS ’24PhD, Xiang Zhu, Ridwan Hussein��’22��and��Mishfak��Mansoor also contributed to the research.��Researchers from��Rensselaer Polytechnic Institute, Weill Cornell Medicine,��Universidade��Federal de Pelotas,��the��University of��Pittsburgh��and��the��University of North Carolina at Chapel��Hill��also��contributed.

This work was supported by the National Science Foundation Award Number (FAIN): 2317758(MMM), Ed and Ethel Moore Alzheimer’s Disease Research Program of the��Florida Department of Health,��Public Health Research, Biomedical Research Program��24A12 (MMM), and the National Science Centre, Poland UMO-2023/51/B/NZ5/00498 (MMM).

Any opinions, findings, and conclusions or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the views of the awarding agencies.

�鶹ӳ����ý College of Medicine Associate Professor Claudia Andl, a throat and oral cancer researcher, is investigating how a simple probiotic could treat and prevent both conditions..

�鶹ӳ����ý College of Medicine Associate Professor Claudia Andl, a throat and oral cancer researcher, is investigating how a simple probiotic could treat and prevent both conditions. The research is funded by a one-year, more than $380,000 grant from the Florida Department of Health’s Florida Cancer Innovation Fund.

Probiotics are live microorganisms — usually bacteria or yeasts — that support and strengthen health by increasing the body’s population of healthy cells. Many people take probiotics to improve gut health and digestion. Andl’s research is focused on using a healthy bacteria called Lactobacillus spp. to treat esophageal damage caused by acid reflux and improve the microbial environment in the esophagus to reduce the risk of cancer.

In patients with acid reflux — as well as gastroesophageal reflux disease (GERD), a chronic and more severe form of the digestive condition — stomach acid burns through the lining of the esophagus, causing inflammation and DNA damage to surrounding cells. Over time, those cellular changes can create a condition called Barrett’s esophagus, which increases the risk for esophageal cancer. In addition, when the throat’s bacterial environment becomes dominated by stomach acids and salts, healthy bacteria struggle to survive. Harmful bacteria take their place, causing further cell damage and inflammation that increases cancer risk. Introducing Lactobacillus spp. into disease models has solved both issues.

“We all talk about how important it is to eat yogurt or drink kombucha so that we maintain a healthy bacterial residence in all your organs. And it’s the same in the esophagus.”

“The reintroduction of beneficial bacteria works two-fold,” Andl says. “It restores a normal environment again, but also these Lactobacilli are known to suppress inflammation and repair the DNA damage.”

“We all talk about how important it is to eat yogurt or drink kombucha so that we maintain a healthy bacterial residence in all your organs,” Andl continues. “And it’s the same in the esophagus.”

Early results have shown a reduction in Barrett’s esophagus, and if cancer develops at all, it occurs much later than in models not treated with the probiotic.

Andl says she hopes her research will inform new therapies and provide more information on how to keep the body’s microbial balance healthy to fight disease. She notes this is especially important as data also shows Barett’s esophagus and esophageal cancer are increasing in patients under ages 60-70, the average age for these patient populations.

“We aim to improve outcomes for the large number of reflux patients at risk for cancer,” Andl says. “Playing a role in that would be incredibly rewarding.”

Andl joined �鶹ӳ����ý in 2016 after receiving her Ph.D. in cell biology from the University Duisburg-Essen in Germany and conducting postdoctoral research at the University of Pennsylvania.

This research is sponsored by the Florida Cancer Innovation Fund and the Florida Department of Health.

Her��research, backed by a five-year $813,130 National Institute of Allergy and Infectious Diseases grant, found that an antimicrobial peptide naturally found in cows weakens the biofilm defenses of Klebsiella pneumoniae bacteria and destroys it.

Now in their fourth year of research, Fleeman and her lab have discovered exactly how the peptide works in findings published in PLOS Pathogens.

“Our research is very advantageous for healthcare because about 80% of bacterial infections being treated in the clinic are bacteria living in a biofilm state, which makes them resistant to virtually every antibiotic available,” she says.

The results��represent��a critical step to potentially applying this peptide as a therapy and eventually treating patients,��as the findings��show they can and kill biofilm-embedded bacteria in animal models.

Parsing out the Peptide

K. pneumoniae is found in the intestines and is usually harmless, however, the bacterium develops resistance over a person’s lifetime as they are exposed to antibiotics. The bacteria also can spread from the intestine to other parts of the body in immunocompromised patients and those who have internal ruptures or exposure to contaminated medical devices. That exposure can lead to pneumonia, urinary tract or wound infections.

“What happens is the bacteria��infects��the wound, proliferates, and then invades through the bloodstream��where it travels��to the liver, kidneys and spleen,” Fleeman��says. “We��found��our peptide��was able to decrease the bacteria��at the source while limiting��the bacteria’s��ability to move��through the blood.”

Fleeman and her lab’s most recent study found that the peptide triggers a dual stress response that tricks the bacteria to break out of their protective biofilm.

They discovered the genetics of a specific protein in the bacterium when turned on in the germ causes it to break from its own protective biofilm. The peptide, in effect, damages the protection and then stresses the bacterium into shedding its protection, making the germ more sensitive to antibiotics and the body’s immune system.

“By��hitting the membrane as well as protein synthesis at the same time, it’s��a double punch that triggers a genetic��change��in the cell to make it think it needs to break out of��the biofilm as a response to our peptide,” Fleeman��says.

The team says their sustained research aims to demonstrate that their peptide can work synergistically with existing antibiotics. They envision long-term applications could involve a topical cream that weakens the bacteria’s defenses and allows standard antibiotics to work more effectively.

“We’re moving our research��forward��and we’re very hopeful,” Fleeman��says.

Preparing for the Post-Antibiotic Era

The first author of this new work��is��Robert Beckman��’23, who graduated��from �鶹ӳ����ý��with a��bachelor’s degree in health sciences,��managed��Fleeman’s lab��and is now on his way to��the University of Michigan��for his Ph.D.

His��previous��work as an EMT gave him firsthand exposure to��infectious diseases and their impact on��patients.��He��says��helping to lead the study and��working with��Fleeman helped prepare him for a career in medical research.

“I have developed a strong foundation in research and gained insight into the many components that define an effective scientist,” he��says. “My long-term goal is to remain in academia and eventually lead my own research lab.��I plan to continue focusing on bacteriology, with a particular emphasis on pathogenic bacteria and drug discovery applications.”

Funding and Disclosure:

Research reported in this publication was supported by the National Institute��of Allergy��and Infectious Diseases of the National Institutes of Health under Award Number R00AI163295. The content is solely the responsibility of the authors and does not necessarily��represent��the official views of the National Institutes of Health.

Dinender Singla, professor and head of the College of Medicine’s Division of Metabolic and Cardiovascular Sciences, developed a system that turns exosomes — vesicles that cells secrete to communicate with one another — into delivery vehicles for medical treatments.

This innovative technology, for which �鶹ӳ����ý is seeking patent protection, places therapeutics inside exosomes and coats them with cell-specific markers that direct them to an exact area of the body to deliver the drug.

“I call these smart tiny bubbles,” Singla says. “Millions of people have heart disease, and they take multiple drugs in extremely high doses. But we have no way to be certain these drugs are getting to where they need to go. We need innovative technologies to get treatments exactly where they need to go to cure the problem.”

How the Therapy Works

This discovery is part of Singla’s work to provide therapies to treat and prevent heart disease, including heart damage caused by cancer treatments such as chemotherapy and targeted radiation to the chest. That heart damage seems to be caused by inflammatory factors that treatments use to kill cancer cells. Technology developed by Singla encapsulates anti-inflammatory heart treatments in exosomes and then delivers the drug to the exact area of heart damage.

“They can treat cancer and protect the heart.” — �鶹ӳ����ý Professor Dinender Singla

As part of this research, Singla’s team also developed technologies to deliver cancer-killing drugs inside exosomes. They chose triple-negative breast cancer for their research, the deadliest form of the disease, with a 77%–78% five-year survival rate. In the lab, the therapy showed significant promise in killing cancer cells – at much lower doses that are used in chemotherapy – while also protecting the heart. So the exosome therapy could help cancer patients without the severe side effects of chemotherapy.

“These therapies can work hand-in-hand,” Singla said. “They can treat cancer and protect the heart.”

Financial Investment is Key for Drug Development

The next step will be manufacturing the therapy for clinical use and advancing into FDA clinical trials for heart disease and cancer treatment. To help accelerate that path, Singla partnered with Orlando investor and �鶹ӳ����ý donor Chakri Toleti, a healthcare technology entrepreneur focused on building category-defining businesses through AI and agentic platforms, biomedical innovation and ambient intelligence including most recently care.ai, which was acquired by Stryker in 2024.

Through his innovation fund, TCapital, Toleti backs transformative technologies designed to improve healthcare delivery and reduce human suffering at scale. Together, Singla and Toleti invested in and formed Exomic to fund continued research, clinical development, and commercialization of the technology.

“This was an opportunity to do something truly innovative in cancer and cardiovascular treatment.” — Chakri Toleti, �鶹ӳ����ý donor

Toleti says his passion for advancing cancer research is deeply personal after losing his father to the disease.

“This was an opportunity to do something truly innovative in cancer and cardiovascular treatment,” he says. “Dr. Singla’s work represents a fundamental shift toward new biomedical platforms not only in how targeted therapies are delivered in the human body, but in how we think about treatment and healing itself.”

Such public-private partnerships are one of the goals of , which drives innovation, enterprise, and collaboration across disciplines.

“Dr. Singla’s groundbreaking exosome delivery system perfectly exemplifies how university innovation translates into significant, life-saving benefits for society,” says Winston V. Schoenfeld, vice president for research and innovation. “As demonstrated by the creation of Exomic, industry partnership is essential for driving such pioneering technologies towards successful translation and real-world clinical use.”

The effort is also providing exciting learning opportunities for College of Medicine graduate students. Jonatas De Mendonca Rolando ’23MS ’26PhD��earned his Ph.D. in biomedical sciences earlier this month. He is staying at �鶹ӳ����ý as a post-doctoral researcher to continue creating the exosome therapy.

He helped develop protocols and procedures for the delicate technology and saw its impact in the lab. He’s excited to have a financial supporter who can help take the therapy from lab to, he hopes, patients.

“It’s been amazing to part of a high-tech project and see leadership in science,” he says. “I am very excited for my future.”

Researcher Background

Singla is the AdventHealth Endowed Chair of Cardiovascular Sciences at the Burnett School of Biomedical Sciences and is a faculty fellow with the �鶹ӳ����ý Office of Research. He earned his bachelor’s and master’s degrees from Punjabi University, Patiala, India, and his Ph.D. from the Post Graduate Institute of Medical Education and Research, Chandigarh, India. He has published more than 100 peer-reviewed papers and has continually been funded by the American Heart Association and/or the National Institutes of Health since 2004.

About TCapital

TCapital is an AI, Frontier Tech and Life Sciences innovation fund investing in category-defining platforms and infrastructure. Founded by healthcare technology entrepreneur Chakri Toleti, T-Capital invests in companies shaping the future of treatment, care, and biomedical innovation. For more information, visit TCapital.com.

All were among 109 College of Medicine graduates who became Physician Knights on May 15 and promised to become what their dean calls one of “the Good Doctors – a �鶹ӳ����ý tradition.”

This year’s M.D. program commencement was the medical school’s 14th and the last for Vice President for Health Affairs and founding Dean Deborah German, who announced earlier this year she will transition from the role she has held for 20 years.

“Graduates, today you become alumni of an innovative medical school committed to improving health for all,” she said. “Through your time here, you learned, you grew, and you cared for patients with courage, dedication, and grace. I couldn’t be prouder of the work you have done.”

With this year’s commencement, �鶹ӳ����ý’s young medical school, which opened in 2009, has prepared 1,421 physicians to care for Floridians and the nation at large.

Inspired by Her Research Mentor

Moots is the third M.D./Ph.D. graduate in �鶹ӳ����ý’s history. She enrolled at the university in 2013 to pursue her bachelor’s degree in biomedical sciences and began her combined doctoral degree in 2018. Now she will go to Lakeland Regional Hospital for internal medicine training – her first choice for residency because of the hospital’s focus on innovation, research and clinical trials.

“I’ve spent almost half my life at �鶹ӳ����ý,” she says. “Graduating is incredibly exciting, but it feels strange to close such a long and meaningful chapter.”

She said her medical training at �鶹ӳ����ý was most shaped by her research mentor, Otto Phanstiel, a College of Medicine cancer researcher. “He exemplifies the qualities I aspire to carry into medicine through the way he communicates, collaborates, and approaches every interaction with humility, curiosity, and a drive for excellence,” she says. “His influence has shaped how I hope to approach research, teamwork, and patient care throughout my career.”

“Most Monumental Moment of My Life”

Shaylor will do his . He hopes to become a hand surgeon. Medical school military officers are promoted when they receive their M.D. degree, and �鶹ӳ����ý’s tradition is to honor that promotion at commencement. After receiving their diplomas, military officers are pinned with their new rank by a faculty member of their choosing.

Shaylor was inspired to enter military service by Jose Borrero, a U.S. Air Force flight surgeon during Vietnam before becoming a founding faculty member at the College of Medicine. Now retired, Borrero continues to serve as a mentor to �鶹ӳ����ý medical students. He returned to commencement May 15, pinned Shaylor and proudly saluted the young military physician. Shaylor describes the pinning as “the most monumental moment of my life.”

Connecting with Others

Castellano and Threatt met playing volleyball during their first year of medical school, then started a band with other M.D. students. They went through the fear of “couples matching” into residency – unsure if they would be selected to train at the same hospital or even city.

Today they’re simultaneously planning their move to Johns Hopkins in Baltimore and their wedding. He’ll practice anesthesiology because it combines his love of chemistry and connecting with people.

“There’s a small window that you have to talk to patients before surgery, but it is one of their most vulnerable moments in which you really have an ability to make this individual feel comfortable,” he says. “That is a very special relationship to me.”

She’s training to be a pediatrician.

“My biggest dream and aspiration is to be an advocate for children and for families,” she says. “I think that through Johns Hopkins there will be a lot of opportunities to do so and go into communities to be helping and educating children.”

When NASA launches its latest voyage to the International Space Station on May 12, it will carry a blood clotting experiment from the �鶹ӳ����ý College of Medicine’s newest faculty member. The research will include illuminated bone marrow cells floating in space to find better ways to keep astronauts and Earthlings healthier.

Hansjorg Schwertz specializes in occupational health and focuses his research on how microgravity and radiation in space impact the body’s blood-clotting functions. After an extensive career overseas and at the University of Utah, he comes to �鶹ӳ����ý to serve as the associate director for Translational Aerospace Medicine Research at the �鶹ӳ����ý Center for Aerospace and Extreme Environments Medicine (CASEEM).

As humans prepare for longer missions to the moon, Mars and beyond, the center is exploring how factors such as microgravity, radiation and isolation impact the human body in space and how that knowledge can drive innovation into diagnostics, treatment and disease prevention for patients on Earth.

“When it comes to putting footprints on the moon, there is no better place to be than �鶹ӳ����ý,” he says.

NASA Concerned About Blood Clots in Space

Pre- and post-mission medical testing of astronauts on the International Space Station has shown that spaceflight changes their immune system and blood clotting ability. A few astronauts have even developed blood clots during a flight or after returning. For that reason, Schwertz is leading the NASA-funded Megakaryocytes Orbiting in Outer Space and Near Earth (MOON) study, which he began working on at the University of Utah and continues to collaborate with the university’s researchers on.

“When it comes to putting footprints on the moon, there is no better place to be than �鶹ӳ����ý.” — Hansjorg Schwertz

Megakaryocytes are bone marrow cells that create platelets, which circulate in the blood stream and can stop bleeding or form blood clots. Both cells also play a key role in immune responses.

The MOON study is examining how space flight affects the development and function of megakaryocytes as they create platelets. The results could provide important knowledge about the risks of inflammation, immune responses and blood clot formation that will help space travelers and patients on Earth, Schwertz says.

His team is sending human cells to the ISS on board the SpaceX 34 resupply mission. Once they are aboard the space station, astronauts will culture the cells and help to develop megakaryocytes in space.

One part of the experiment is to watch the cells in real time, and how they develop their “daughter cell,” the platelets. Because the research will be in microgravity, the cells will float. They’ll be stained with fluorescent dye so �鶹ӳ����ý’s researcher can examine them remotely at better accuracy.

Schwertz says mentors taught him, “seeing is believing,” so he is “genuinely excited” to see megakaryocytes float in space.

Advancing Personalized Medicine

One of the challenges of space medicine research is that so few people have gone to space, so the sample pool is small. As space travel and colonization progress, more people will be traveling to and working on the moon and beyond.

Healthwise, many will be different than astronauts who are selected after going through vigorous testing and selection criteria. Thus, space is a new frontier of healthcare.

Schwertz hopes his study will unlock technologies and therapies to keep astronauts’ blood clotting mechanisms controlled, prevent abnormal clotting and bring those discoveries back to Earth.

“We’re examining the impact of space flight on each person’s cells,” he says. “This is personalized medicine, and isn’t that what healthcare is all about?”

Emmanuel Urquieta, vice chair for Aerospace Medicine at the �鶹ӳ����ý College of Medicine and founding director of CASEEM, Schwertz’s work reflects the program’s broader mission to connect spaceflight research with practical clinical and operational solutions.

“Our aerospace medicine program is intentionally designed to be operational and translational in nature,” Urquieta says. “We are building a program that can support the real medical needs of exploration missions while rapidly translating discoveries from spaceflight and extreme environments into innovations that improve health here on Earth.”

Schwertz received his M.D. and Ph.D. from the School of Medicine at the University of Mainz, Germany. After a residency in Internal Medicine/Cardiology at the University of Halle, Germany, he did a post-doctoral fellowship at the University of Utah, where he also served as faculty.

In 2012, he ��was awarded a prestigious Lichtenberg-Professorship for Experimental Hemostasis and returned to Germany where he directed a research laboratory. He returned to Utah in 2015, where he completed his residency training in Occupational Medicine and was a faculty member, researcher and community physician.

The material is based upon work supported by NASA under award No. 80NSSC22K0255. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Aeronautics and Space Administration.

�鶹ӳ����ý is the leading producer of talent among Florida’s universities, awarding nearly 19,000 degrees annually to Knights who go on to work in high-demand industries. About 85% of our alumni stay in Florida because of the ample opportunity to thrive as part of our state’s workforce.

Graduates will hear from six esteemed speakers whose leadership and impact span some of Central Florida’s most influential industries:

• Barry Miller ’95, president of Voloridge Investment Management
• Brian Adams ’04MBA, president and CEO of AdventHealth Central Florida Division
• Gloria Caulfield, vice president of strategic alliances, Tavistock Development Company
• Barbara Gellman-Danley, president of Higher Learning Commission
• Maj. Gen. James Smith, commander, space training and readiness command at Patrick Space Force Base
• Peter Lee, president of Microsoft Science

Commencement Festivities

Held in the Addition Financial Arena, spring commencement will take place over six ceremonies spanning Friday, May 8, and Saturday, May 9.

All guests, including children and infants, need a ticket for admission. All graduates who have filed an intent to graduate will receive five commencement ceremony tickets when they pick up their regalia packet.

Guests who do not have tickets may watch the live ceremony via a simulcast viewing in the FAIRWINDS Alumni Center and the Student Union. Ceremonies will also be livestreamed .

Commencement Photo-ops Across �鶹ӳ����ý

Graduating Knights are unable to take photos at the Acrisure Bounce House Stadium this semester due to ongoing construction.

Grad Walk

On Thursday, May 7, 2:30-7 p.m. (doors close at 6 p.m.), spring graduates are invited to a photo-op — Grad Walk — within the Addition Financial Arena. This will be a first-come, first-served occasion for graduates and up to 10 of their well-wishers to take photos and videos on the ceremony stage. Graduates are required to .

Commencement Schedule

Graduates and guests can review the below commencement ceremony schedule, listing colleges, ceremony dates and streaming links:

Friday, May 8

9 a.m.

College of Business

Rosen College of Hospitality Management

2 p.m.

College of Health Professions and Sciences

College of Medicine

College of Nursing

7 p.m.

College of Arts and Humanities

Nicholson School of Communication and Media

Saturday, May 9

9 a.m.

College of Community Innovation and Education

2 p.m.

College of Sciences (excluding Nicholson School of Communication and Media)

7 p.m.

College of Engineering and Computer Science

College of Graduate Studies

College of Optics and Photonics

For more details and FAQs about Spring 2026 commencement celebrations, visit ucf.edu/graduation.

Commencement Speakers

Barry Miller ’95

President of Voloridge Investment Management

Barry Miller ’95 serves as president of Voloridge Investment Management, quantitative hedge fund manager, and Voloridge Health, a data science-based health tech company, both Florida based.

Miller, who graduated with honors from �鶹ӳ����ý with a bachelor’s degree in finance, recently made a transformational $50 million gift this spring to establish the Barry S. Miller College of Business at �鶹ӳ����ý. The largest single philanthropic investment in �鶹ӳ����ý history, the gift will accelerate a bold new model of business education designed for a world where technology, data and decision-making are inseparable.

Miller, also a member of the �鶹ӳ����ý College of Business Hall of Fame, brings years of executive experience, having previously served as CEO of LASAS Technologies, a finance and insurance company that he co-founded in 1998. His career experience includes financial analysis, capital raising, financial markets, actuarial experience, software development and in-depth company infrastructure formation.

After gaining valuable experience as an entrepreneur and chief executive officer, Miller’s ambition led him to join and invest in Voloridge Investment Management and then Voloridge Health. For both companies, he is responsible for many facets of leadership, including trading, back-office operations, compliance, sales and marketing, vendor relationships and strategic planning.

Brian Adams ’04MBA

President and CEO of AdventHealth Central Florida Division

Brian Adams is president and CEO of AdventHealth’s Central Florida Division, one of the nation’s largest faith-based health systems, whose 37,000 dedicated team members provide care for more than 3 million patients.

Known for building high-performing teams and ensuring the organization grows to meet the care needs of the community, Adams has led efforts to expand access to care, elevate quality and bring innovative solutions to rapidly growing communities. His leadership has continued to position AdventHealth as a trusted and innovative partner in Central Florida.

As a part of AdventHealth for more than 24 years, Adams has held senior leadership roles across the organization, including CEO positions in Tampa and Polk County, where he oversaw major expansions, facility investments and quality improvements.

He earned his master’s of business administration from the �鶹ӳ����ý and a bachelor’s degree from Union College in Nebraska. Originally from Oshawa, Ontario, Canada, Adams and his wife have two teenage sons.

Gloria Caulfield

Vice president of strategic alliances, Tavistock Development Company

In her multifaceted role as vice president of strategic alliances at Tavistock, Gloria Caulfield manages business development and corporate partnerships, collaborates with national and global stakeholders to advance health innovation, and leads the development of cutting-edge strategies for the Lake Nona community.

She is the chief architect and creative force behind the Lake Nona Impact Forum. The revered global health innovation summit brings together many of the world’s most preeminent thought leaders and serves as a signature event of the Tavistock Group.

Caulfield serves on boards that reflect her passion for advancing the future of human health, including the StartUp Health Impact Board, which focuses on mobilizing entrepreneurs to solve the biggest health challenges of our time, and the LFE Capital Advisory Board, which supports female founders and impactful, wellness-oriented companies.

Prior to joining Tavistock, she had a distinguished career at AdventHealth. As senior executive director for community development, she provided strategic leadership for corporate partnerships and spearheaded critical community initiatives across Central Florida. Caulfield is an alumna of the University of Arizona and brings visionary leadership to every aspect of her work.

Barbara Gellman-Danley

President of Higher Learning Commission

Barbara Gellman-Danley is president of the Higher Learning Commission, which accredits colleges and universities to ensure they meet high-quality standards and continuously improve.

Prior to beginning this role in 2014, she was president of the University of Rio Grande/Rio Grande Community College in Ohio. She previously served as vice chancellor of the Ohio Board of Regents, president of Antioch University McGregor, vice president at Monroe Community College and vice chancellor at the Oklahoma State Regents for Higher Education.

Gellman-Danley sits on the boards of Credential Engine, which she chairs, and GlobalMindED. Her career includes previous board and commission memberships with the Association of Governing Boards Council of Presidents, the National Council for State Authorization Reciprocity Agreements, the American Council on Education’s Education and Attainment group and the Council on Adult and Experiential Learning.

Gellman-Danley holds degrees from Syracuse University, Simmons University, Oklahoma City University and the University of Oklahoma. She did post-graduate work at New York University, Cornell, Harvard, the University of Chicago and MIT.

An honorary member of Phi Theta Kappa, she is a professional certified coach, certified executive coach and certified life coach. She holds certifications in change management, Agile and Lean Six Sigma, a professional credential validating expertise in data-driven process improvement aimed at reducing waste and defects.

Maj. Gen. James Smith

Commander, space training and readiness command at Patrick Space Force Base

As commander, Maj. Gen. James E. Smith is responsible for preparing the U.S. Space Force and more than 14,000 military and civilian guardians to prevail in competition and conflict through innovative education, training, doctrine and test activities.

Originally from Boise, Idaho, Maj. Gen. Smith commissioned in 1997 as the top graduate of the U.S. Air Force Academy. His career spans numerous space operations and acquisition positions, including command at the squadron, group, wing, garrison and Field Command levels.

Maj. Gen. Smith has deployed to Afghanistan in support of Operation Enduring Freedom and to the U.S. Embassy in Iraq in support of Operation Inherent Resolve. Prior to his current position, Maj. Gen. Smith served as the vice director, Joint Force Development, J-7, the Joint Staff, Arlington, Virginia.

Peter Lee

President of Microsoft Science

Peter Lee is president of Microsoft Science, where his responsibility is to accelerate the pace of discovery in the physical, biological and medical sciences through the use of artificial intelligence and other emerging technologies.

Previously, he led the world laboratories of Microsoft Research. Before joining Microsoft in 2010, he established a new technology office at the Defense Advanced Research Projects Agency within the U.S. Department of Defense, creating operational capabilities in machine learning, data science and computational social science.

From 1987 to 2010, Lee was a professor and the head of the computer science department at Carnegie Mellon University. He is a member of the National Academy of Medicine and serves on the boards of several institutions in AI and medicine, including the board of trustees of the Mayo Clinic and the board of directors of the Kaiser Permanente School of Medicine. He served on President Obama’s Commission on Enhancing National Cybersecurity and has testified before both U.S. House and Senate committees.

He is the co-author of the book, The AI Revolution in Medicine: GPT-4 and Beyond. In 2024, Lee was named by Time magazine as one of the 100 most influential people in health and life sciences.

Four outstanding undergraduate students are redefining the boundaries of STEM through their high-impact research — and in doing so, placing the university among the nation’s top producers of Goldwater Scholars.

The prestigious Goldwater Scholarship identifies and supports the nation’s best student researchers in the fields of engineering, mathematics and natural sciences.

This year’s honorees — all expected to graduate next spring — have propelled �鶹ӳ����ý into an elite tier of research institutions, surpassing several Ivy League institutions and tying for fourth in the nation in total Goldwater Scholars produced alongside Stanford University, the University of Notre Dame and the University of Chicago. Their impactful work reflects �鶹ӳ����ý’s commitment to building a high-level research environment that empowers students to lead projects addressing significant global and scientific challenges.

Supporting Space Exploration

Goldwater Scholar: Keanu Brayman

Major: Mechanical engineering

Ultimate Goal: To develop robotic systems to support human exploration on Mars.

Keanu Brayman’s passion for space began early.

“One of my earliest memories is watching a Space Shuttle streak across the sky from a beach in South Florida,” Brayman says. “I remember being amazed there were people on board and feeling drawn to one day help explore the stars and discover what lies beyond our planet.”

At �鶹ӳ����ý, Brayman has refined that dream with the support of faculty and mentors — including Department of Physics Chair and Professor Adrienne Dove, Associate Professor of Mechanical and Aerospace Engineering Tarek Elgohary and NASA Marshall Space Flight Center Engineer Christopher Proctor — as well as through programs like the .

He plans to pursue a doctoral degree in aerospace engineering to support lunar exploration and NASA’s Artemis program, as well as develop robotic systems that can extract resources and build infrastructure to support human exploration on Mars.

Engineering the Brain

Goldwater Scholar: Kyle Coutray

Majors: Computer engineering and biomedical sciences

Ultimate Goal: To research ways to restore communication, movement and cognitive function to the brain through engineering methods.

Kyle Coutray is focused on the intersection of neuroscience and technology.

“I’m interested in building systems that interact directly with the brain,” Coutray says. “In the lab, … [I’m] blending [both majors] into one approach.”

He aims to pursue a doctoral degree in neural engineering to further his research on brain-computer interfaces that translate complex brain activity into useful functions.

A 2026 Order of Pegasus inductee and a Burnett Honors Scholar, Coutray credits his success to disciplined focus and strong mentorship, particularly from Charles N. Millican Professor of Computer Science Joseph LaViola and Associate Professor of Mechanical and Aerospace Engineering Helen Huang.

Advancing Patient Care

Goldwater Scholar: Varun Nannuri

Major: Molecular and cellular biology

Ultimate Goal: To pursue a career as a physician-scientist.

Varun Nannuri is driven by a desire to understand why people experience different health outcomes and improve care.

“Through my clinical experiences, I have seen how much patients and families rely on physicians during some of the most difficult moments of their lives,” Nannuri says. “My research experiences have shown me that better care depends on asking better questions.”

Nannuri plans to pursue a dual M.D./Ph.D. degree and become a physician-scientist. His ambition earned him recognition as a 2026 Order of Pegasus inductee while also completing his Honors Undergraduate Thesis. Nannuri is also a member of the Burnett Honors College as a Burnett Medical Scholar, a program that offers guaranteed admission to the �鶹ӳ����ý College of Medicine upon completion.

“�鶹ӳ����ý has given me opportunities to grow as a student, researcher, leader and future physician,” Nannuri says.

Restoring Human Senses

Goldwater Scholar: Trevor Overton

Majors: Electrical engineering and biomedical sciences

Ultimate Goal: To improve the lives of people with disabilities through advanced robotic prostheses.

Burnett Honors Scholar Trevor Overton’s work centers on neuroengineering and next-generation prosthetics.

“I’ve always had a passion for building things, and I also love reading and watching sci-fi,” Overton says. “When �鶹ӳ����ý offered me the opportunity to join the MEDD [ … I knew I had to take it.”

�鶹ӳ����ý’s MEDD program provides scientifically driven students like Overton with a unique opportunity to integrate engineering principles into medicine.

Much like the development of cochlear implants, Overton imagines similar breakthroughs with vision and touch.

“I envision a future where robotic prostheses are so advanced that they could completely replace or enhance the abilities of humans,” Overton says. “It’s not entirely impossible.”

After earning a doctoral degree in electrical engineering with a focus on neuroengineering, he hopes to inspire the next generation — just as his professors inspired him — emphasizing that �鶹ӳ����ý’s strength lies in professors who actively invest in their students.

A Growing Research Powerhouse

With four 2026 Goldwater Scholarship recipients, �鶹ӳ����ý continues to strengthen its position as a leader in undergraduate research. The achievement reflects both students’ immense dedication and a university-wide commitment to driving innovation, mentorship and hands-on discovery. As these Knights prepare for the next steps in their academic journeys, they carry forward a shared mission: to turn research into real-world impact.

Students interested in applying for the Goldwater Scholarship or other major national awards should contact the Office of Prestigious Awards at��opa@ucf.edu.